Latest Breaking News On - Nicholas keen - Page 1 : comparemela.com

Poppy Appeal launch in Benidorm

The official launch of the Royal British Legion Spain North Poppy Appeal took place in Benidorm on Saturday (October 14), led by Torrevieja Pipes & Drums. The sound of the bagpipes attracted the attention of people along the Levante promenade, who quickly lined the route, applauding as they a

United kingdomBob chambersStephen mcgloryRichard seabrookJohn boissonSara munsterhjelmBritish embassyTorrevieja pipesStandard bearersToni perCaptain stephen mcgloryNicholas keenCosta blanca

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomDavid borahSarah suttonExchange commissionBicycle toxin conjugateMolecular cancerToxin conjugateNicholas keenChief scientific officerMolecular cancer therapeuticsCancer research united kingdom centrePrivate securities litigation reform actQuarterly reportCapital marketsInvestor relationsBicycle therapeutics

Bicycle Therapeutics (BCYC) Announces Publication of Preclinical Data from BT8009 Program

Bicycle Therapeutics (BCYC) Announces Publication of Preclinical Data from BT8009 Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bicycle toxin conjugateMolecular cancerToxin conjugateNicholas keenChief scientific officerMolecular cancer therapeutics

Bicycle Therapeutics plc: Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics

Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced

United kingdomDavid borahSarah suttonExchange commissionBicycle therapeuticsBicycle toxin conjugateMolecular cancerNicholas keenChief scientific officerMolecular cancer therapeuticsCancer research united kingdom centrePrivate securities litigation reform actQuarterly reportCapital markets investor relations

Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Prog

CAMBRIDGE, England & BOSTON (BUSINESS WIRE) Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that an article highlighting preclinical data from BT7480, a Bicycl.

United kingdomUnited statesDavid borahSarah suttonExchange commissionBicycle therapeuticsSynthetic classNicholas keenChief scientific officerBicycle toxin conjugateCancer research united kingdom centrePrivate securities litigation reform actQuarterly reportCapital marketsInvestor relations